Skip to content

The influence of genetic variations on Migraine

The influence of dopamine-related genetic polymorphisms on susceptibility and behavior of Migraine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9wgwnj
Enrollment
Unknown
Registered
2020-03-11
Start date
2018-08-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine with aura [classical migraine]

Interventions

living conditions and habits
inventory pharmacological
physical examination with vital data
complete neurological examination
POPULATION AND INTERVENTION: Patients treated from two sources will be invited to participate in the study: (1) Outpatient clinic Neurology, Hospital de Clínicas, UFPR
and (2) private offices for employees. Three groups will be recruited: patients with migraine episodic, patients with chronic migraine and control. Since CM cases are less frequent than their non-chro
presence of prodromal and post-dermal symptoms (defined as different headache symptoms occurring up to 72 h before or after the pain crisis)
morbid history and factors comorbid with migraine
family history (up to 2nd grade)
and complementary exams according to clinical judgment. The degree of disability with migraine will be assessed through the Migraine Disability Assessment (MIDAS) (FRAGOSO, 2002). The tool for analysi
Genetics
Other

Sponsors

Hospital de Clinicas da Universidade Federal do Paraná.
Lead Sponsor
Hospital de Clinicas da Universidade Federal do Paraná.
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Will be included individuals who meet the diagnostic criteria for migraine without aura, migraine with aura and / or chronic migraine associated or not with abuse of analgesics; are between 18 and 65 years of age at the time of inclusion; accept to participate in the study on a voluntary basis. The control group will include people who do not suffer from headache and for that, they should answer negatively to the question: "Have you ever suffered from frequent headaches and without an obvious cause?". Patients with complaints other than headache will be invited, employees of recruiting institutions, escorts of patients with no familiarity with the study group, volunteers recruited from disclosure by verbal approach or physical media and electronic.

Exclusion criteria

Exclusion criteria: Will be excluded from the study individuals who do not complete all applied scales; present other types of headache concomitantly, such as trigeminal neuralgia and secondary headaches; withdraw the informed consent form.

Design outcomes

Primary

MeasureTime frame
Evaluate the proportion of polymorphisms in genes related to SAM using methods of comparison of quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.

Secondary

MeasureTime frame
Evaluate the frequency of specific signs and symptoms using methods of comparing quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.;Evaluate the proportion of patients with known factors of chronification by means of comparison methods of quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.;Evaluate the proportion of analgesic abuse using methods of comparison of quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.;Evaluate the frequency of “dopaminergic” symptoms (such as yawning) using methods of comparing quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.;Evaluate the proportion of refractory cases using methods of comparing quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control. ;Evaluate the proportion of comorbidities using methods of comparing quantitative and qualitative variables seeking to observe differences between the 3 groups evaluated: episodic migraine, chronic migraine and control.

Countries

Brazil

Contacts

Public ContactElcio Piovesan

Hospital de Clinicas da Universidade Federal do Paraná.

piovesan1@hotmail.com5541999719567

Outcome results

None listed

Source: REBEC (via WHO ICTRP)